Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses
about
CefepimePharmacokinetics of cefepime in patients with thermal burn injury.Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniaePharmacokinetics of cefepime during continuous venovenous hemodiafiltrationFuture directions in antimicrobial chemotherapy.Pharmacokinetic disposition and bactericidal activities of cefepime, ceftazidime, and cefoperazone in serum and blister fluid.Effects of age and gender on pharmacokinetics of cefepimePharmacokinetics of cefepime dihydrochloride arginine in subjects with renal impairment.Cefepime: a reappraisal in an era of increasing antimicrobial resistance.Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring.Pitfalls in cefepime titration from human plasma: plasma- and temperature-related drug degradation in vitroPharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects.Lack of pharmacokinetic interaction between cefepime and amikacin in humansPharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.Comparison of the antibacterial effects of cefepime and ceftazidime against Escherichia coli in vitro and in vivo.High-performance liquid chromatographic determination and pharmacokinetic study of cefepime in goat plasma and milk after pre-column derivatization with Hg(I).Cefepime versus ceftazidime in the treatment of lower respiratory tract infections.
P2860
Q29040262-B7C8C1BB-7728-4BB6-9604-2471B3684B0AQ33978205-9F520B69-261A-4B93-A337-11B6F329FA2AQ35136019-01B5C313-22B0-43CD-BC17-B4343D7A0504Q35138871-B5523688-1EFD-411E-B35D-87339B61D74DQ35530705-C1CFEF5A-EF40-4AE7-92E6-1F1EDA52687CQ35826273-D9D1EDCA-BBC8-4B7B-B2E8-5F73C0D712E9Q35862379-970B2606-D6DD-422E-A355-9469C12EFDBBQ36758208-B9BE28E4-2CDF-4B81-B0FE-355226357DB9Q37079350-9A515F92-F9C1-47C5-8794-ADCA962060CEQ37334702-5F9F1038-CA77-4B77-81B1-2FE451641838Q39657986-432F9977-E8E5-4B9E-9139-AA3EA3F3DCF4Q39875827-C75349E8-CBDC-49A0-B4FF-9352147661F8Q39879612-F812321F-4A26-4040-AB2C-B93BCE2E2A07Q39879617-20BCC2F9-28F5-41FD-AFB8-035D34E11D8AQ40284499-CF097266-220D-4AEF-A255-61E2098D662DQ42929512-D4076636-5BCE-47C6-AB12-67E7C3137D5EQ44533712-13546EE9-2D0E-4B09-8174-B9788FAB64A1
P2860
Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Safety, tolerance, and pharmac ...... on of single intravenous doses
@ast
Safety, tolerance, and pharmac ...... on of single intravenous doses
@en
Safety, tolerance, and pharmac ...... on of single intravenous doses
@nl
type
label
Safety, tolerance, and pharmac ...... on of single intravenous doses
@ast
Safety, tolerance, and pharmac ...... on of single intravenous doses
@en
Safety, tolerance, and pharmac ...... on of single intravenous doses
@nl
prefLabel
Safety, tolerance, and pharmac ...... on of single intravenous doses
@ast
Safety, tolerance, and pharmac ...... on of single intravenous doses
@en
Safety, tolerance, and pharmac ...... on of single intravenous doses
@nl
P2093
P2860
P356
P1476
Safety, tolerance, and pharmac ...... on of single intravenous doses
@en
P2093
C R Gleason
D J Weidler
K A Pittman
R H Barbhaiya
R R Martin
S T Forgue
P2860
P304
P356
10.1128/AAC.34.6.1118
P407
P577
1990-06-01T00:00:00Z